Redmile Group, LLC Igm Biosciences, Inc. Transaction History
Redmile Group, LLC
- $1.28 Billion
- Q4 2024
A detailed history of Redmile Group, LLC transactions in Igm Biosciences, Inc. stock. As of the latest transaction made, Redmile Group, LLC holds 2,952,131 shares of IGMS stock, worth $4.07 Million. This represents 1.41% of its overall portfolio holdings.
Number of Shares
2,952,131
Previous 3,072,478
3.92%
Holding current value
$4.07 Million
Previous $50.8 Million
64.51%
% of portfolio
1.41%
Previous 3.32%
Shares
6 transactions
Others Institutions Holding IGMS
# of Institutions
86Shares Held
19.5MCall Options Held
61.3KPut Options Held
36.7K-
Baker Bros. Advisors LP New York, NY4.09MShares$5.65 Million0.28% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.57MShares$4.93 Million0.0% of portfolio
-
Siren, L.L.C. New York, NY3.33MShares$4.6 Million0.9% of portfolio
-
Goldman Sachs Group Inc New York, NY978KShares$1.35 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA896KShares$1.24 Million0.0% of portfolio
About IGM Biosciences, Inc.
- Ticker IGMS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,969,000
- Market Cap $40M
- Description
- IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...